CClinicalTrials.gg
CompletedNCT05877976Updated Jan 22, 2025Results posted

Impact of Visual Arts Immersion

An interventional study of Visual Arts Immersion in Cultural Competency and Personal Reflection, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-22.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
41
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to enhance engagement, coping and self-reflection by attuning nurses to creative and observational skills drawn from a visual arts pedagogical framework. To fulfill this goal, the investigators will cultivate an existing relationship between NYU Langone Health (NYULH) Nursing, the NYU Health Sciences Library, and museum educators at The Met to design and deliver an intervention of museum educator-led workshops that introduce nurses to arts appreciation skills to improve their practice and overall wellbeing. Participants will be asked to complete two surveys, pre- and post-intervention, Cultural Awareness Scale (CAS), which measures cultural awareness, sensitivity, knowledge and skills, and the Interpersonal Reactivity Index (IRI), which measures four separate aspects of empathy and its relationships with measures of social functioning, self-esteem, emotionality, and sensitivity to others. We will also solicit qualitative feedback via REDCap survey at the end of the intervention to gain insight into nurse's experiences of the art immersion program.

02

Conditions studied

  • Cultural Competency
  • Personal Reflection
03

In context

Lead sponsor

NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.

Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. A Registered Nurse at NYULH
  2. Willing to provide an email address or cell phone number of choice
  3. Willing to attend one workshop in person at The MET and one virtually via WebEx
  4. Willing and able to provide consent
  5. Age 18 years of age or older

Exclusion criteria

Exclusion Criteria:

  1. Not a Registered Nurse at NYULH
  2. Not willing to provide an email address or cell phone number of choice
  3. Not willing to attend one workshop in person at The MET and one virtually via WebEx
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
41 participants (actual)

Study arms

  • Experimental
    Registered Nurses

    Participants will receive an intervention of museum educator-led workshops that introduce nurses to arts appreciation skills to improve their practice and overall wellbeing.

    Behavioral: Visual Arts Immersion

Interventions

  • BehavioralVisual Arts Immersion

    Museum educators from The Metropolitan Museum of Art (MET) will provide a curriculum including an art immersion program that will select specific works/art in the museum as well as virtually that will help to stimulate self-reflection and prompt connection to their nursing practice. Participants will be asked to sign up for 2 art immersion classes. The first class will be an in-person class at The MET and the second class will be virtual via WebEx. Each class will last 60 minutes.

06

What researchers measure

Primary outcomes

  1. Change in Cultural Awareness Scale (CAS) Score From Baseline to Month 6

    36-item questionnaire assessing cultural awareness, sensitivity, knowledge and skills. Each item is rated on a 7-point scale (ranging from "strongly disagree" to "strongly agree"). The total score ranges from 0-252. Lower scores indicate less cultural awareness, and higher scores indicate greater awareness.

    Time frame: Baseline, Month 6

  2. Change in Clinical Interpersonal Reactivity Index (CIRI) Score From Baseline to Month 6

    27-item questionnaire evaluating empathy as a reaction in interpersonal relationships at the bedside. Items are ranked on a scale from 0-4, where 0 = does not describe me well; and 4 = describes me very well. The total score ranges from 0 to 108; higher scores indicate greater empathy.

    Time frame: Baseline, Month 6

07

Results

Posted Jan 22, 2025

Participant flow

Participant flow — Overall Study
MilestoneRegistered Nurses
Started41
Completed10
Not completed31
Withdrew: Lost to follow-up31

Outcome measures

PrimaryChange in Cultural Awareness Scale (CAS) Score From Baseline to Month 6

36-item questionnaire assessing cultural awareness, sensitivity, knowledge and skills. Each item is rated on a 7-point scale (ranging from "strongly disagree" to "strongly agree"). The total score ranges from 0-252. Lower scores indicate less cultural awareness, and higher scores indicate greater awareness.

Time frame:
Baseline, Month 6
Reported as:
Mean · score on a scale
Change in Cultural Awareness Scale (CAS) Score From Baseline to Month 6
score on a scaleRegistered Nurses
Change in Cultural Awareness Scale (CAS) Score From Baseline to Month 611.90 (-1.32 to 25.12)
PrimaryChange in Clinical Interpersonal Reactivity Index (CIRI) Score From Baseline to Month 6

27-item questionnaire evaluating empathy as a reaction in interpersonal relationships at the bedside. Items are ranked on a scale from 0-4, where 0 = does not describe me well; and 4 = describes me very well. The total score ranges from 0 to 108; higher scores indicate greater empathy.

Time frame:
Baseline, Month 6
Reported as:
Mean · score on a scale
Change in Clinical Interpersonal Reactivity Index (CIRI) Score From Baseline to Month 6
score on a scaleRegistered Nurses
Change in Clinical Interpersonal Reactivity Index (CIRI) Score From Baseline to Month 64.7 (0.10 to 9.30)

Adverse events

Collected over Month 6. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Registered Nurses0/41 (0%)0/41 (0%)0/41 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Registered Nurses
Mean49.2 ± 16.75
Sex: Female, Male
Sex: Female, Male(Participants)Registered Nurses
Female10
Male0
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Registered Nurses
Hispanic or Latino0
Not Hispanic or Latino10
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Registered Nurses
American Indian or Alaska Native0
Asian2
Native Hawaiian or Other Pacific Islander0
Black or African American1
White7
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Registered Nurses
United States10
08

Study locations

1 site
  • NYU Langone Health
    New York, New York 10016, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jan 16, 2024
  • Informed consent form · Jun 19, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — This study is only open to NYU Langone Health Employees.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05877976
Lead sponsor
NYU Langone Health
Collaborators
National Library of Medicine (NLM)
Responsible party
Sponsor
First posted
May 26, 2023
Start date
Jun 15, 2023
Primary completion
Mar 21, 2024
Completion
Mar 21, 2024
Results posted
Jan 22, 2025
Last update
Jan 22, 2025

Study contacts

Lita Anglin
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion